PRIA Logo™
117-hr-7515117th Congress

Infectious Disease Therapies Research and Innovation Act of 2022

Sponsored By: Representative Kelly, Mike [R-PA-16]

Unknown

Summary

Infectious Disease Therapies Research and Innovation Act of 2022 This bill exempts from the definition of passive activity, for purposes of the passive loss tax rules, any qualified medical research activity of a specified medical research small business pass-thru entity. The bill defines specified medical research small business pass-thru entity as any domestic pass-thru entity if more than 80% of such entity's expenditures on research are paid or incurred in connection with qualified medical research activities and the gross receipts of such entity for the taxable year are less than $1 million.

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & CoSponsors

Sponsor

Kelly, Mike [R-PA-16]

PA • R

Cosponsors

  • Rep. Buchanan, Vern [R-FL-16]

    FL • R

    Sponsored 4/14/2022

  • Rep. Wenstrup, Brad R. [R-OH-2]

    OH • R

    Sponsored 4/14/2022

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation